Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects

NCT01776697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: pelubiprofen (30mg) tablet IR
DRUG: pelubiprofen SR (as a pelubiprofen 90 mg) tablet

Sponsor

Daewon Pharmaceutical Co., Ltd.